TilyardM.W., SpearsG.F.S., ThomsonJ., DoveyS.Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med1992; 326: 357–62.
7.
ChapuyM.C., ArlotM.E., DuboeufF.Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med1992; 327: 1637–42.
8.
PatelS.R., KeH.Q., HsuC.H.Regulation of calcitriol receptor and its mRNA in normal and renal failure rats. Kidney Int1994; 45: 1020–7.
9.
PatelS.R., Qiong KeH., VanholderR., HsuC.H.Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. Kidney Int1994; 46: 129–33.
10.
HsuC.H., PatelS.R., YoungE.W.Mechanism of decresed calcitriol degradation in renal failure. Am J Physiol1992; 262: F192–8.
11.
BrownA.J., DussoA., Lopez-HilkerS., Lewis-FinchJ., GroomsP., SlatopolskyE.1,25 (OH)2D3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int1989; 35: 19–23.
12.
HsuC.H., PatelR.S., VanholderR.Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. Am J Physiol1993; 264: F662–9.
13.
HowardG., NguyenT., MorrisonN.Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab1995; 80: 2800–5.
14.
CarlingT., KindmarkA., HellmanP.Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Med1995; 1: 1309–11.
15.
FukudaN., TanakaH., TominagaY., FukagawaM., KurokawaK., SeinoY.Decreased 1,25-dihydroxycalcitriol 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest1993; 92: 1436–43.
16.
ArnoldA., BrownM.F., UrenaP., GazR.D., SarfatiE., DruekeT.B.Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest1995; 95: 2047–53.
17.
FalchettiA., BaleA.F., AmorosiA.Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab1993; 76: 139–44.
